• Day One Biopharmaceuticals' (DAWN) "Buy" Rating Reiterated at Needham & Company LLC

    Source: Buzz FX / 13 Jan 2025 10:46:16   America/Chicago


    Day One Biopharmaceuticals' (DAWN) "Buy" Rating Reiterated at Needham & Company LLC Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Day One Biopharmaceuticals ( NASDAQ:DAWN - Get Free Report ) 's stock had its "buy" r
    Read more...
Share on,